In summary, we found that the zinc transporter SLC39A7 is highly expressed in high-grade glioma patients with a poor prognosis and can activate the TNF-α-mediated NF-κB signaling pathway, thereby promoting the proliferation, invasion and migration of glioma cells. Here, TNF is linked to central nervous system cancer.